Targeting bacterial adherence inhibits multidrug-resistant Pseudomonas aeruginosa infection following burn injury
Ryan M Huebinger1, Daniel H Stones2, Marcela de Souza Santos3
1Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abstract:
Classical antimicrobial drugs target proliferation and therefore place microbes under extreme selective pressure to evolve resistance. Alternative drugs that target bacterial virulence without impacting survival directly offer an attractive solution to this problem, but to date few such molecules have been discovered. We previously discovered a widespread group of bacterial adhesins, termed Multivalent Adhesion Molecules (MAMs) that are essential for initial binding of bacteria to host tissues and virulence. Thus, targeting MAM-based adherence is a promising strategy for displacing pathogens from host tissues and inhibiting infection. Here, we show that topical application of polymeric microbeads functionalized with the adhesin MAM7 to a burn infected with multidrug-resistant Pseudomonas aeruginosa substantially decreased bacterial loads in the wound and prevented the spread of the infection into adjacent tissues. As a consequence, the application of this adhesion inhibitor allowed for vascularization and wound healing, and maintained local and systemic inflammatory responses to the burn. We propose that MAM7-functionalized microbeads can be used as a topical treatment, to reduce bacterial attachment and hence prevent bacterial colonization and infection of wounds. As adhesion is not required for microbial survival, this anti-infective strategy has the potential to treat multidrug-resistant infections and limit the emergence of drug-resistant pathogens.
Insights
New microbead treatment targets bacterial adhesion, not survival, to combat multidrug-resistant infections. This approach reduces bacterial load and promotes wound healing without driving further resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Biomaterials
Background:
- Classical antibiotics exert selective pressure, driving antimicrobial resistance.
- Targeting bacterial virulence factors offers an alternative strategy to combat infections.
- Multivalent Adhesion Molecules (MAMs) are key bacterial adhesins essential for host tissue colonization.
Purpose of the Study:
- To investigate the potential of targeting MAM-based adherence as an anti-infective strategy.
- To evaluate the efficacy of MAM7-functionalized microbeads in treating multidrug-resistant bacterial wound infections.
Main Methods:
- Developed polymeric microbeads functionalized with the adhesin MAM7.
- Applied microbeads topically to burn wounds infected with multidrug-resistant Pseudomonas aeruginosa.
- Assessed bacterial load, infection spread, wound healing, and inflammatory responses.
Main Results:
- Topical application of MAM7-functionalized microbeads significantly reduced bacterial loads in infected wounds.
- The treatment prevented the spread of infection to adjacent tissues.
- MAM7 microbeads promoted wound vascularization and healing while maintaining appropriate inflammatory responses.
Conclusions:
- MAM7-functionalized microbeads represent a promising topical treatment for reducing bacterial attachment and preventing wound colonization.
- This anti-infective strategy, by not targeting microbial survival, has the potential to treat multidrug-resistant infections and limit the emergence of new resistant pathogens.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...


